Contributors: Institut Català de la Salut; Candel FJ Clinical Microbiology & Infectious Diseases, Transplant Coordination, IdISSC & IML Health Research Institutes, Hospital Clínico Universitario San Carlos, Madrid, Spain. Salavert M Infectious Diseases Unit, La Fe (IIS) Health Research Institute, University Hospital La Fe, Valencia, Spain. Basaras M Immunology, Microbiology and Parasitology Department, Faculty of Medicine and Nursing, University of País Vasco, Bizkaia, Spain. Borges M Multidisciplinary Sepsis Unit, Intensive Medicine Department, University Hospital Son Llàtzer, Palma de Mallorca, Spain. Instituto de Investigación Sanitaria Islas Baleares (IDISBA), Mallorca, Spain. Cantón R Clinical Microbiology Service, University Hospital Ramón y Cajal, Institute Ramón y Cajal for Health Research (IRYCIS), Madrid, Spain. CIBER of Infectious Diseases (CIBERINFEC), National Institute of Health San Carlos III, Madrid, Spain. Cercenado E Clinical Microbiology & Infectious Diseases Service, University Hospital Gregorio Marañón, Madrid, Spain. Polverino E Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER of Respiratory Diseases (CIBERES), Institute of Health San Carlos III, Madrid, Spain; Vall d'Hebron Barcelona Hospital Campus
نبذة مختصرة : Aetiology; Community acquired pneumonia; Radiologic findings ; Etiologia; Pneumònia adquirida a la comunitat; Troballes radiològiques ; Etiología; Neumonía adquirida en la comunidad; Hallazgos radiológicos ; Community-acquired pneumonia represents the third-highest cause of mortality in industrialized countries and the first due to infection. Although guidelines for the approach to this infection model are widely implemented in international health schemes, information continually emerges that generates controversy or requires updating its management. This paper reviews the most important issues in the approach to this process, such as an aetiologic update using new molecular platforms or imaging techniques, including the diagnostic stewardship in different clinical settings. It also reviews both the Intensive Care Unit admission criteria and those of clinical stability to discharge. An update in antibiotic, in oxygen, or steroidal therapy is presented. It also analyzes the management out-of-hospital in CAP requiring hospitalization, the main factors for readmission, and an approach to therapeutic failure or rescue. Finally, the main strategies for prevention and vaccination in both immunocompetent and immunocompromised hosts are reviewed.
Processing Request
No Comments.